Get started
Author

Jørgen Ingerslev

Definitions in Hemophilia
2001 · Frits Rosendaal, Louis Aledort, et al. · Thrombosis and Haemostasis · 788
Recombinant Activated Factor VII for Adjunctive Hemorrhage Control in Trauma
2001 · Uri Martinowitz, Gili Kenet, et al. · The Journal of Trauma: Injury, Infection, and Critical Care · 441
Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)
2006 · Anne Goodeve, Jeroen Eikenboom, et al. · Blood · 392
PDF
Clinical phenotypes and factor VII genotype in congenital factor VII deficiency
2005 · Guglielmo Mariani, Falko Herrmann, et al. · Thrombosis and Haemostasis · 259
Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD
2008 · Giancarlo Castaman, Stefan Lethagen, et al. · Blood · 202
PDF
Consensus recommendations for the diagnosis and treatment of acquired hemophilia A
2010 · Peter Collins, Francesco Baudo, et al. · BMC Research Notes · 195
PDF
Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis
2003 · Benny Sørensen, Peter Johansen, et al. · Blood Coagulation & Fibrinolysis · 177
Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
2008 · Sandra L. Haberichter, Giancarlo Castaman, et al. · Blood · 166
Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders
2010 · Christian Fenger‐Eriksen, Gary W. Moore, et al. · Transfusion · 131
Clinical Use of Recombinant FVIIa (rFVIIa)
1998 · Ulla Hedner, Jørgen Ingerslev · Transfusion Science · 130
Fibrinogen concentrate – a potential universal hemostatic agent
2009 · Christian Fenger-Eriksen, Jørgen Ingerslev, et al. · Expert Opinion on Biological Therapy · 123
Diagnostic Performance and Therapeutic Consequence of Thromboelastometry Activated by Kaolin versus a Panel of Specific Reagents
2011 · Ole Halfdan Larsen, Christian Fenger-Eriksen, et al. · Anesthesiology · 114
PDF
Efficacy and Safety of Recombinant Factor VIIa in the Prophylaxis of Bleeding in Various Surgical Procedures in Hemophilic Patients with Factor VIII and Factor IX Inhibitors
2000 · Jørgen Ingerslev · Seminars in Thrombosis and Hemostasis · 111
Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation – the surgical STER
2010 · Guglielmo Mariani, Alberto Dolce, et al. · British Journal of Haematology · 83
PDF
Femoral head blood flow reduction and hypercoagulability under 24 h megadose steroid treatment in pigs
2003 · Wolf Drescher, Karen P. Weigert, et al. · Journal of Orthopaedic Research® · 77
PDF
Use of recombinant factor VIIa (NovoSeven®) in patients with Glanzmann thrombasthenia
2001 · Man-Chiu Poon, Roseline d'Oiron, et al. · Seminars in Hematology · 77
High homocysteine and thrombosis without connective tissue disorders are associated with a novel class of cystathionine β-synthase (CBS) mutations
2002 · Kenneth N. Maclean, Mette Gaustadnes, et al. · Human Mutation · 71
Two novel type 2N von Willebrand disease–causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor
2000 · Simon Allen, Adel M. Abuzenadah, et al. · Blood · 71
Parallel use of by‐passing agents in haemophilia with inhibitors: a critical review
2011 · Jørgen Ingerslev, Benny Sørensen · British Journal of Haematology · 70
PDF
A novel von Willebrand disease–causing mutation (Arg273Trp) in the von Willebrand factor propeptide that results in defective multimerization and secretion
2000 · Simon Allen, Adel M. Abuzenadah, et al. · Blood · 70
Acute von Willebrand Factor Secretion from the Endothelium In Vivo: Assessment through Plasma Propeptide (vWf:AgII) Levels
1997 · Ulrich M Vischer, Jørgen Ingerslev, et al. · Thrombosis and Haemostasis · 68
von Willebrand Factor (vWf) as a Plasma Marker of Endothelial Activation in Diabetes: Improved Reliability with Parallel Determination of the vWf Propeptide (vWf:AgII)
1998 · Jef Emeis, Henk Bilo, et al. · Thrombosis and Haemostasis · 65
Prevalence of Congenital Homocystinuria in Denmark
1999 · Mette Gaustadnes, Jørgen Ingerslev, et al. · New England Journal of Medicine · 64
Factor VIIa analogue (V158D/E296V/M298Q‐FVIIa) normalises clot formation in whole blood from patients with severe haemophilia A
2007 · Benny Sørensen, Egon Persson, et al. · British Journal of Haematology · 63
The Origin of Cerebrospinal Fluid Somatostatin: Hypothalamic or Disperse Central Nervous System Secretion?
2008 · Kurt V. Sørensen, Stig Engkjœr Christensen, et al. · Neuroendocrinology · 60
Works count: 121
Citation count: 5,423
H-index: 36
I10-index: 74
Year
Topic
Type